NCT06780410View on ClinicalTrials.gov

A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid

PHASE3RecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Primary Hyperlipidemia
Interventions
DRUG

Bempedoic Acid Tablet

Once daily, oral

DRUG

Placebo

Once daily, oral

Trial Locations (1)

Unknown

RECRUITING

Site 01, Beijing

Sponsors
All Listed Sponsors
lead

Gan & Lee Pharmaceuticals.

INDUSTRY